GH $70.78

2.56 (3.5%)


GH Profile

MEMBERSHIP
--
SECTOR
Health Care
MARKET CAPITALIZATION

$7 Billion

Mid-Cap
Guardant Health Inc is a precision oncology company. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. The company only reportable segment: delivering precision oncology testing and development services. Geographically, the company generates a majority of its revenue from the United States. its solutions include treatment selection, recurrence, and early detection.

GH Earnings

EPS

-0.14

P/E

--

Q2 Earnings for Apr, May & Jun

Tue, Aug 6, 2019

Since Earnings Report

GH -18.9%

Q3 Earnings for Jul, Aug & Sep

Thu, Nov 7, 2019

Since Earnings Report

GH +9.5%

GH Dividend

Dividend Yield

0.00%

Dividend Rate

$0.00

Ex-Dividend Date

--

Dividend Pay Date

--

Dividend Frequency

--

Dividend Payments

--

GH Charts

52W Low $32.33
52W High $112.22
All-Time $112.22


GH Industry Competitors


MEDICAL DIAGNOSTICS & RESEARCH
Koninklijke Philips N.V. NY Registry Shares
DexCom
Exact Sciences
Bio-Rad Laboratories Inc
Qiagen NV
Icon PLC
Bruker Corp
Charles River Laboratories International Inc
PRA Health Sciences Inc
Syneos Health, Inc. - Class A Common Stock



Symbol MC DY Price Day YTD
GH $6.89 0.00% $70.78 -3.5% 93.9%





Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com



    TOP    

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy Terms Of Service Privacy Policy